Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Vitamin D411 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24117 | 23213074 | Hepatology | Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. | 2013 | Details |
| A24482 | 22850810 | Wien Klin Wochenschr | The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24554 | 22753133 | Hepatology | Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. | 2012 | Details |
| A24579 | 22730920 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk. | 2012 | Details |
| A24666 | 22634121 | J Hepatol | D-livering the message: the importance of vitamin D status in chronic liver disease. | 2012 | Details |
| A25098 | 22173168 | J Hepatol | The interaction of hepatic lipid and glucose metabolism in liver diseases. | 2011 | Details |
| A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |
| A25293 | 21988593 | Diabet Med | Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. | 2012 | Details |
| A25295 | 21987619 | World J Gastroenterol | Spleen: A new role for an old player? | 2011 | Details |
| A25417 | 21876630 | World J Gastroenterol | Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. | 2011 | Details |
| A25418 | 21876629 | World J Gastroenterol | Nutritional recommendations for patients with non-alcoholic fatty liver diseases. | 2011 | Details |
| A25517 | 21749681 | BMC Med | Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. | 2011 | Details |
| A25671 | 21562784 | Dig Dis Sci | Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome. | 2011 | Details |
| A25806 | 21440524 | Clin Res Hepatol Gastroenterol | Vitamin D and the vitamin D receptor in liver pathophysiology. | 2011 | Details |
| A25917 | 21331294 | J Obes | Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. | 2011 | Details |
| A26031 | 21184788 | J Hepatol | Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. | 2010 | Details |
| A26248 | 20842109 | Am J Gastroenterol | Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. | 2010 | Details |
| A26623 | 20079722 | Chem Biol Interact | Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. | 2010 | Details |
| A27947 | 16928437 | Nutr Metab Cardiovasc Dis | Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A29341 | 34231046 | J Gastroenterol | Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. | 2021 | Details |
| A29342 | 34228859 | Hepatol Res | Evidence-based clinical practice guidelines for liver cirrhosis 2020. | 2021 | Details |
| A33286 | 26300934 | Hepat Mon | Parathyroid Hormone Levels May Predict Nonalcoholic Steatohepatitis in Morbidly Obese Patients. | 2015 | Details |
| A34154 | 24303091 | World J Hepatol | Increased bone mineral density in patients with non-alcoholic steatohepatitis. | 2013 | Details |
| A34631 | 23029000 | PLoS One | VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. | 2012 | Details |
| A34780 | 22624776 | Implement Sci | An interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial. | 2012 | Details |
| A34805 | 22564878 | J Intensive Care Med | Characteristics of patients with the "malignant obesity hypoventilation syndrome" admitted to an ICU. | 2012 | Details |
| A34874 | 22359532 | PLoS One | Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. | 2012 | Details |
| A35772 | 19721198 | Clin Calcium | [Hepato-biliary and pancreatic disease and osteodystrophy]. | 2009 | Details |
| A37065 | 16535923 | Recenti Prog Med | [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?]. | 2006 | Details |
| A42359 | 34767670 | Biofactors | Vitamin D3 enhances the effects of omega-3 oils against metabolic dysfunction-associated fatty liver disease in rat. | 2021 | Details |
| A42426 | 34561721 | Eur J Pediatr | Correction to: Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. | 2022 | Details |
| A42470 | 34449134 | Obesity (Silver Spring) | Salmon peptides limit obesity-associated metabolic disorders by modulating a gut-liver axis in vitamin D-deficient mice. | 2021 | Details |
| A42503 | 34358825 | Clin Nutr | Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. | 2021 | Details |
| A42742 | 33596631 | J Biol Regul Homeost Agents | Vitamin D3 supplementation in controlling metabolic changes associated with non-alcoholic steatohepatitis. | 2021 | Details |
| A42853 | 33282605 | Cureus | Effects of Oxidant-Antioxidant and Vitamin D Levels on Clinical and Laboratory Data in Children With Fatty Liver Disease. | 2020 | Details |
| A43020 | 32795138 | J Am Coll Nutr | Vitamin D and Wellbeing beyond Infections: COVID-19 and Future Pandemics. | 2020 | Details |
| A43185 | 32353356 | Metabolism | Commentary: Obesity: The "Achilles heel" for COVID-19? | 2020 | Details |
| A43486 | 31592705 | Metab Syndr Relat Disord | Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A43654 | 31180389 | North Clin Istanb | The relationship between vitamin D level and hepatosteatosis in obese children. | 2018 | Details |
| A43695 | 31089553 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60). | 2018 | Details |
| A43696 | 31089552 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60). | 2018 | Details |
| A43837 | 30744928 | J Clin Densitom | Bone Health in Patients With Liver Diseases. | 2019 | Details |
| A43841 | 30734078 | Chirurg | [Metabolic surgery]. | 2019 | Details |
| A44345 | 28901968 | Curr Opin Obstet Gynecol | Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review. | 2017 | Details |
| A44377 | 28776742 | Aliment Pharmacol Ther | Letter: non-alcoholic fatty liver disease and polycystic ovary syndrome-evidence for low vitamin D status contributing to the link. | 2017 | Details |
| A44494 | 28469226 | Am J Gastroenterol | Vitamin D's Role in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A44495 | 28469220 | Am J Gastroenterol | Reply to Kim et al. | 2017 | Details |
| A44561 | 28211513 | Nat Rev Endocrinol | NAFLD: Vitamin D-induced autophagy prevents steatosis. | 2017 | Details |
| A44609 | 27986351 | Nutr Metab Cardiovasc Dis | Serum 25-hydroxyvitamin D, non-alcoholic fatty liver disease and type 2 diabetes. | 2016 | Details |
| A44678 | 27435327 | Dig Dis Sci | Targeting Hepatic Fibrosis in Autoimmune Hepatitis. | 2016 | Details |
| A44817 | 27193136 | J Am Assoc Nurse Pract | An evidence-based resource for the management of comorbidities associated with childhood overweight and obesity. | 2016 | Details |
| A44929 | 26743253 | Zhonghua Gan Zang Bing Za Zhi | [Role of vitamin D deficiency in nonalcoholic fatty liver disease]. | 2015 | Details |
| A45024 | 26405717 | J Gastrointestin Liver Dis | Metabolomics for genomics: the role of vitamin D in nonalcoholic fatty liver disease. | 2015 | Details |
| A45050 | 26294696 | Gut | High-dose vitamin D supplementation and liver histology in NASH. | 2015 | Details |
| A45066 | 26206563 | Hepatology | Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link. | 2015 | Details |
| A45186 | 25774554 | Endocrinology | Vitamin d deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. | 2015 | Details |
| A45199 | 25714573 | J Pediatr Gastroenterol Nutr | The vitamin D controversy. | 2015 | Details |
| A45261 | 25489472 | Ther Adv Endocrinol Metab | Vitamin D insufficiency and insulin resistance in obese adolescents. | 2014 | Details |
| A45295 | 25342734 | Diabetes | Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. | 2014 | Details |
| A45323 | 25192564 | Gut | Vitamin D and liver fibrosis: let's start soon before it's too late. | 2014 | Details |
| A45353 | 25073467 | Pharmacol Rev | Bile acid signaling in metabolic disease and drug therapy. | 2014 | Details |
| A45368 | 24971027 | J Inflamm Res | Vitamin D and inflammatory diseases. | 2014 | Details |
| A45418 | 24727882 | Minerva Med | Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease. | 2014 | Details |
| A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
| A45639 | 23503327 | Endocr J | Comments on "High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome". | 2013 | Details |
| A45640 | 23495130 | Liver Transpl | High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. | 2013 | Details |
| A45672 | 23330546 | Drug Metab Rev | Nuclear receptors in bile acid metabolism. | 2013 | Details |
| A45698 | 23236625 | Curr Opin Clin Nutr Metab Care | Bibliography. Micronutrients. Current world literature. | 2012 | Details |
| A45767 | 22862874 | Mayo Clin Proc | Why vitamin D status should be checked in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45816 | 22570973 | J Pediatr Endocrinol Metab | Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. | 2012 | Details |
| A46080 | 21236303 | J Hepatol | Shedding new light on vitamin D and fatty liver disease. | 2011 | Details |
| A46182 | 20513013 | Hepatology | Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A46980 | 31463983 | Lipids | Vitamin D Deficiency Attenuates Acute Alcohol-Induced Hepatic Lipid Accumulation in Mice. | 2019 | Details |
| A47591 | 6219359 | Presse Med | [Influence of chronic alcoholism on plasma 25-hydroxycholecalciferol levels]. | 1983 | Details |
| A47879 | 30194503 | Glycoconj J | Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice. | 2018 | Details |
| A47993 | 27027234 | J Med Food | Extracts from Lentinula edodes (Shiitake) Edible Mushrooms Enriched with Vitamin D Exert an Anti-Inflammatory Hepatoprotective Effect. | 2016 | Details |
| A48079 | 24726754 | Gastroenterology | Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. | 2014 | Details |
| A48293 | 17222588 | Clin Gastroenterol Hepatol | Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. | 2007 | Details |
| A48637 | 32616182 | Bioorg Med Chem | N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR). | 2020 | Details |
| A48815 | 27728806 | Cancer Cell | p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. | 2016 | Details |
| A48872 | 25954093 | World J Gastroenterol | Role of vitamins in gastrointestinal diseases. | 2015 | Details |
| A48873 | 25941109 | Alcohol Clin Exp Res | Severe Vitamin D Deficiency May be an Additional Cofactor for the Occurrence of Alcoholic Steatohepatitis. | 2015 | Details |
| A49204 | 35829988 | J Endocrinol Invest | Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional study. | 2022 | Details |
| A49389 | 35766555 | Asia Pac J Clin Nutr | Metabolic dysfunction associated fatty liver disease (MAFLD) and serum vitamin D concentration in South Korea. | 2022 | Details |
| A49754 | 35646540 | Acta Pharm Sin B | Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | 2021 | Details |
| A49782 | 35639173 | J Bone Miner Metab | Association between non-alcoholic fatty liver disease and bone turnover markers in southwest China. | 2022 | Details |
| A49861 | 35616069 | Food Funct | Walnut green husk ethanol extract improves gut microbiota and their metabolites associated with NLRP3 in non-alcoholic steatohepatitis. | 2022 | Details |
| A50049 | 35546181 | Sci Rep | Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. | 2022 | Details |
| A50132 | 35508444 | Eur J Intern Med | Uric acid in metabolic syndrome: Does uric acid have a definitive role? | 2022 | Details |
| A50245 | 35460237 | J Clin Endocrinol Metab | Resolution of, and Risk of Incident Non-alcoholic Fatty Liver Disease With Changes in Serum 25-hydroxy Vitamin D Status. | 2022 | Details |
| A50679 | 35305348 | Biomed Pharmacother | Jiangzhi granule attenuates non-alcoholic steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet. | 2022 | Details |
| A50790 | 35265372 | J Nutr Metab | The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery. | 2022 | Details |
| A50818 | 35170370 | Scand J Gastroenterol | Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based study. | 2022 | Details |
| A51020 | 24988092 | Minerva Med | Vitamin D and NAFLD: the need for interventional trials. | 2014 | Details |
| A51418 | 35677501 | J Clin Exp Hepatol | High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study. | 2021 | Details |
| A51522 | 35631255 | Nutrients | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. | 2022 | Details |
| A51646 | 35292606 | Gut Liver | Osteoporosis Is Associated with an Increased Risk of Colorectal Adenoma and High-Risk Adenoma: A Retrospective, Multicenter, Cross-Sectional, Case-Control Study. | 2022 | Details |
| A51723 | 34596865 | Hepatol Int | Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection. | 2021 | Details |
| A51757 | 34322432 | J Family Med Prim Care | Metabolic complications of childhood obesity. | 2021 | Details |
| A51881 | 33487256 | Clin Nutr ESPEN | Nutraceuticals for the treatment of sarcopenia in chronic liver disease. | 2020 | Details |